ANNOUNCING OUR INVESTMENT IN NUMI
We’re excited to announce our investment in Nūmi’s $3m Seed round, a Paris-based biotech start-up pioneering the production of cell-cultured breast milk.
OUR INVESTMENT IN LAMBDA AUTOMATA'S $6M SEED ROUND
Founded by former Apple and Palantir engineers, the company develops dual-use autonomous surveillance towers powered by AI.
HCVC BACKS ORAKL ONCOLOGY IN 3M€ SEED ROUND
The company develops a techbio platform enabling the oncology industry to meet the challenge of personalized medicine.
AUTOMATA (HCVC'18) RAISES $40M LED BY DIMENSION
The new round will allow Automata to further expand Linq, its leading lab automation platform
ANNOUNCING OUR NEW $75M SEED FUND
The new fund is going to back pre-seed and seed hardtech companies primarily in Europe and North America.
ANTARIS (HCVC'22) REACHES $10M IN FUNDING WITH NEW ROUND
This will allow the leading software provider for space to further accelerate development of the Antaris Cloud Platform.
QASHIER (HCVC'20) RAISES A $10M SERIES A
The round, co-led by Delivery Hero Ventures and IFP Securities, will help Qashier boost its footprint in the global payments landscape
FIRST ZERO SESSION IN NYC CO-HOSTED WITH USV
Our debut ZERO session at USV on June 1st was sold out and featured a fireside chat with Albert Wenger and presentations from Ark Biotech and Osmoses.
SPAN (HCVC'18) CLOSES NEW $96M SERIES B2 ROUND
The new round will allow Span to accelerate on its mission to electrify 10 million homes by 2030.
AUGMENTA (HCVC'19) ACQUIRED BY CNH INDUSTRIAL FOR $110M
HCVC lead Augmenta's seed round in 2019 and the company is now joining forces with CNH Industrial, one of the leaders in the precision agriculture space.
RENAISSANCE FUSION RAISES €15M SEED FOR ITS FUSION REACTOR
The round will enable the Grenoble-based startup further develop its novel stellarator fusion reactor.
GIRAFFE360 (HCVC'20) RAISES $16M SERIES LED BY FOUNDERS FUND
The round will help Giraffe360 expand their AI-based virtual tour solutions for real estate agents.
SARCURA RAISES €7M TO REVOLUTIONIZE CELL THERAPY MANUFACTURING
HCVC is thrilled to partner with Sarcura in its mission to build a lab-on-chip platform for the manufacturing of advanced cell therapies.
ALCATRAZ AI (HCVC'18) RAISES $25M SERIES A
Alcatraz AI uses 3D facial authentication and AI for autonomous access control, removing the need for badges or security guards.